Targeting mitochondrial RNA modifications in aggressive leukemia
Targeting mitochondrial RNA methylation in high-risk acute myeloid leukemia
This study is looking at how changes in mitochondrial RNA might affect leukemia stem cells in people with acute myeloid leukemia (AML), with the goal of finding new ways to treat this tough-to-treat blood cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beckman Research Institute/city of Hope NIH-funded |
| Lab location | 1 site (Duarte, United States) |
| Project ID | NIH-11024644 on NIH RePORTER |
What this research studies
This research focuses on acute myeloid leukemia (AML), a severe blood cancer that often remains untreatable. The study aims to understand how modifications to mitochondrial RNA can influence the behavior of leukemia stem cells, which are responsible for the disease's initiation and relapse. By investigating the role of mitochondrial metabolism and RNA modifications, the researchers hope to identify new therapeutic strategies to eliminate these cancerous cells. The approach includes analyzing large datasets to pinpoint specific vulnerabilities in AML that can be targeted for treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with acute myeloid leukemia, particularly those with MLL rearrangements or FLT3 internal tandem duplications.
Not a fit: Patients with other types of leukemia or those whose AML does not involve the specific genetic alterations being studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that effectively target and eliminate leukemia stem cells, potentially improving outcomes for AML patients.
How similar studies have performed: Previous research has shown promise in targeting RNA modifications in cancer, suggesting that this approach could be effective, although the specific focus on mitochondrial RNA in AML is relatively novel.
Where this research is happening
Duarte, United States
- Beckman Research Institute/city of Hope — Duarte, United States (Active)
Researchers
- Principal investigator: Su, Rui — Beckman Research Institute/city of Hope
- Study coordinator: Su, Rui
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.